Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Cash from Financing Activities (2020 - 2025)

Oncology Institute's Cash from Financing Activities history spans 6 years, with the latest figure at $3.7 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 2376.83% year-over-year to $3.7 million; the TTM value through Dec 2025 reached $11.6 million, up 430.96%, while the annual FY2025 figure was $11.6 million, 430.96% up from the prior year.
  • Cash from Financing Activities reached $3.7 million in Q4 2025 per TOI's latest filing, down from $10.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $136.1 million in Q4 2021 to a low of -$10.7 million in Q2 2022.
  • Average Cash from Financing Activities over 5 years is $12.4 million, with a median of -$801500.0 recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: plummeted 290609.68% in 2021, then skyrocketed 1317537.5% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at $136.1 million in 2021, then crashed by 100.62% to -$847000.0 in 2022, then crashed by 110.27% to -$1.8 million in 2023, then skyrocketed by 90.79% to -$164000.0 in 2024, then soared by 2376.83% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Cash from Financing Activities are $3.7 million (Q4 2025), $10.6 million (Q3 2025), and $2.0 million (Q2 2025).